117 related articles for article (PubMed ID: 25990106)
21. Outcome of primary treatment of early laryngeal malignancies using photodynamic therapy.
von Beckerath MP; Reizenstein JA; Berner AL; Nordqvist KW; Landström FJ; Löfgren AL; Möller CG
Acta Otolaryngol; 2014 Aug; 134(8):852-8. PubMed ID: 24856450
[TBL] [Abstract][Full Text] [Related]
22. [Local curative treatment of superficial adenocarcinoma in Barrett's esophagus. First results of photodynamic therapy with a new photosensitizer].
Etienne J; Dorme N; Bourg-Heckly G; Raimbert P; Fékété F
Bull Acad Natl Med; 2000; 184(8):1731-44; discussion 1744-7. PubMed ID: 11471391
[TBL] [Abstract][Full Text] [Related]
23. Photodynamic therapy for palliation of nonresectable bile duct cancer--preliminary results with a new diode laser system.
Zoepf T; Jakobs R; Arnold JC; Apel D; Rosenbaum A; Riemann JF
Am J Gastroenterol; 2001 Jul; 96(7):2093-7. PubMed ID: 11467637
[TBL] [Abstract][Full Text] [Related]
24. A phase II study of uracil-tegafur plus doxorubicin and prognostic factors in patients with unresectable biliary tract cancer.
Furuse J; Okusaka T; Ohkawa S; Nagase M; Funakoshi A; Boku N; Yamao K; Yamaguchi T; Sato T
Cancer Chemother Pharmacol; 2009 Dec; 65(1):113-20. PubMed ID: 19404641
[TBL] [Abstract][Full Text] [Related]
25. Photodynamic therapy for non-resectable perihilar cholangiocarcinoma.
Kiesslich T; Wolkersdörfer G; Neureiter D; Salmhofer H; Berr F
Photochem Photobiol Sci; 2009 Jan; 8(1):23-30. PubMed ID: 19247524
[TBL] [Abstract][Full Text] [Related]
26. A randomised phase II trial of weekly high-dose 5-fluorouracil with and without folinic acid and cisplatin in patients with advanced biliary tract carcinoma: results of the 40955 EORTC trial.
Ducreux M; Van Cutsem E; Van Laethem JL; Gress TM; Jeziorski K; Rougier P; Wagener T; Anak O; Baron B; Nordlinger B;
Eur J Cancer; 2005 Feb; 41(3):398-403. PubMed ID: 15691639
[TBL] [Abstract][Full Text] [Related]
27. Photodynamic therapy for cholangiocarcinoma: overview and new developments.
Ortner MA
Curr Opin Gastroenterol; 2009 Sep; 25(5):472-6. PubMed ID: 19550314
[TBL] [Abstract][Full Text] [Related]
28. Adjuvant photodynamic therapy for bile duct carcinoma after surgery: a preliminary study.
Nanashima A; Yamaguchi H; Shibasaki S; Ide N; Sawai T; Tsuji T; Hidaka S; Sumida Y; Nakagoe T; Nagayasu T
J Gastroenterol; 2004 Nov; 39(11):1095-101. PubMed ID: 15580404
[TBL] [Abstract][Full Text] [Related]
29. ERCP-directed radiofrequency ablation and photodynamic therapy are associated with comparable survival in the treatment of unresectable cholangiocarcinoma.
Strand DS; Cosgrove ND; Patrie JT; Cox DG; Bauer TW; Adams RB; Mann JA; Sauer BG; Shami VM; Wang AY
Gastrointest Endosc; 2014 Nov; 80(5):794-804. PubMed ID: 24836747
[TBL] [Abstract][Full Text] [Related]
30. Biliary drainage, photodynamic therapy and chemotherapy for unresectable cholangiocarcinoma with jaundice.
Fuks D; Bartoli E; Delcenserie R; Yzet T; Celice P; Sabbagh C; Chatelain D; Joly JP; Cheron N; Dupas JL; Regimbeau JM
J Gastroenterol Hepatol; 2009 Nov; 24(11):1745-52. PubMed ID: 19780885
[TBL] [Abstract][Full Text] [Related]
31. Temoporfin-mediated photodynamic therapy in patients with advanced, incurable head and neck cancer: A multicenter study.
Tan IB; Dolivet G; Ceruse P; Vander Poorten V; Roest G; Rauschning W
Head Neck; 2010 Dec; 32(12):1597-604. PubMed ID: 20848401
[TBL] [Abstract][Full Text] [Related]
32. Two cases of bile duct carcinoma patients who underwent the photodynamic therapy using talaporfin sodium (Laserphyrin
Nanashima A; Hiyoshi M; Imamura N; Hamada T; Nishida T; Kawakami H; Ban T; Kubota Y; Nakashima K; Yano K; Wada T; Takeno S; Kai M
Clin J Gastroenterol; 2020 Feb; 13(1):102-109. PubMed ID: 31222455
[TBL] [Abstract][Full Text] [Related]
33. Oxaliplatin as first-line treatment in inoperable biliary tract carcinoma: a multicenter phase II study.
Androulakis N; Aravantinos G; Syrigos K; Polyzos A; Ziras N; Tselepatiotis E; Samonis G; Kentepozidis N; Giassas S; Vamvakas L; Georgoulias V
Oncology; 2006; 70(4):280-4. PubMed ID: 17047399
[TBL] [Abstract][Full Text] [Related]
34. MicroRNAs associated with the efficacy of photodynamic therapy in biliary tract cancer cell lines.
Wagner A; Mayr C; Bach D; Illig R; Plaetzer K; Berr F; Pichler M; Neureiter D; Kiesslich T
Int J Mol Sci; 2014 Nov; 15(11):20134-57. PubMed ID: 25380521
[TBL] [Abstract][Full Text] [Related]
35. Capecitabine plus cisplatin as first-line chemotherapy for advanced biliary tract cancer: a retrospective single-center study.
Woo SM; Lee WJ; Han SS; Park SJ; Kim TH; Koh YH; Kim HB; Hong EK; Park JW; Kim CM
Chemotherapy; 2012; 58(3):225-32. PubMed ID: 22831988
[TBL] [Abstract][Full Text] [Related]
36. Benefits and safety of photodynamic therapy in patients with hilar cholangiocarcinoma: A meta-analysis.
Chen P; Yang T; Shi P; Shen J; Feng Q; Su J
Photodiagnosis Photodyn Ther; 2022 Mar; 37():102712. PubMed ID: 34995788
[TBL] [Abstract][Full Text] [Related]
37. Preliminary clinical report on safety and efficacy of photodynamic therapy using talaporfin sodium for malignant gliomas.
Akimoto J; Haraoka J; Aizawa K
Photodiagnosis Photodyn Ther; 2012 Jun; 9(2):91-9. PubMed ID: 22594978
[TBL] [Abstract][Full Text] [Related]
38. Short-term effects and adverse events of endoscopically applied radiofrequency ablation appear to be comparable with photodynamic therapy in hilar cholangiocarcinoma.
Schmidt A; Bloechinger M; Weber A; Siveke J; von Delius S; Prinz C; Schmitt W; Schmid RM; Neu B
United European Gastroenterol J; 2016 Aug; 4(4):570-9. PubMed ID: 27536367
[TBL] [Abstract][Full Text] [Related]
39. Early phase II study of uracil-tegafur plus doxorubicin in patients with unresectable advanced biliary tract cancer.
Furuse J; Okusaka T; Funakoshi A; Yamao K; Nagase M; Ishii H; Nakachi K; Ueno H; Ikeda M; Morizane C; Horikawa Y; Mizuno N
Jpn J Clin Oncol; 2006 Sep; 36(9):552-6. PubMed ID: 16887837
[TBL] [Abstract][Full Text] [Related]
40. Photodynamic therapy using talaporfin sodium (Laserphyrin®) for bile duct carcinoma: a preliminary clinical trial.
Nanashima A; Abo T; Nonaka T; Nonaka Y; Morisaki T; Uehara R; Ohnita K; Fukuda D; Murakami G; Tou K; Kunizaki M; Hidaka S; Tsuchiya T; Takeshita H; Nakao K; Nagayasu T
Anticancer Res; 2012 Nov; 32(11):4931-8. PubMed ID: 23155262
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
